Response to Belimumab Among Patients With Systemic Lupus Erythematosus in Clinical Practice Settings: 24-Month Results From the OBSErve Study in the USA
Lupus Science and Medicine - United Kingdom
doi 10.1136/lupus-2015-000118
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2016
Authors
Publisher
BMJ